Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.6486714488930976e-23,inf,inf,"['RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS5', 'RPSA', 'RPS3A', 'RPL24', 'RPL26', 'RPL29', 'UBA52', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS23']",4.929527632190362e-21,0,0,55
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,3.6552864205294756e-17,inf,inf,"['COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UQCRFS1', 'ATP5MF', 'COX8A', 'ATP5PF', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6']",5.464653198691566e-15,0,0,40
3,Nonalcoholic fatty liver disease WP4396,5.7991589612861086e-11,14.081125827814569,331.9023181415065,"['NDUFA13', 'COX7B', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'SOCS3', 'UQCRFS1', 'COX8A', 'XBP1', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS']",5.779828431415155e-09,0,0,35
4,Mitochondrial CIV Assembly WP4922,1.253108512671015e-07,inf,inf,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",9.366986132215838e-06,0,0,17
5,Oxidative phosphorylation WP623,2.393419254374299e-07,29.879032258064516,455.5169814063401,"['ATP5PF', 'NDUFB7', 'NDUFA6', 'NDUFA11', 'NDUFB10', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFB2', 'NDUFC2', 'ATP5MC3', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1B', 'NDUFS6', 'NDUFS5', 'ATP5MF']",1.4312647141158308e-05,0,0,19
6,Mitochondrial complex I assembly model OXPHOS system WP4324,2.014320265075728e-05,21.84,236.14813761988293,"['NDUFA13', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF3']",0.0010038029320960712,0,0,14
7,Mitochondrial complex III assembly WP4921,0.0014880690309987841,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.06356180575266235,0,0,7
8,Pyrimidine metabolism WP4022,0.003426572968870483,12.361331220285262,70.16532216062271,"['POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.12566271154642739,0,0,8
9,Cori Cycle WP1946,0.003782489645210189,inf,inf,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.12566271154642739,0,0,6
10,Alzheimer's disease WP2059,0.006920706072923178,5.156332803391627,25.643667561812233,"['PSENEN', 'ATP5MD', 'CDK5', 'BAD', 'LPL', 'CYCS', 'CALM3', 'CALM1', 'GAPDH', 'CALM2']",0.20692911158040303,0,0,10
11,Ciliary landscape WP4352,0.00823897715387841,4.256369426751593,20.4258021757059,"['PSMD8', 'EXOSC4', 'ARHGDIA', 'NEFL', 'COPS7A', 'DYNLRB1', 'CALM1', 'DYNLL1', 'COX6C', 'CALM2', 'LSM4']",0.22395037900087678,0,0,11
12,7q11.23 copy number variation syndrome WP4932,0.011190014238710492,6.1743264659271,27.73960325591196,"['ATP5F1B', 'CFL1', 'HMGA1', 'ATP5MC3', 'GAPDH', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1']",0.27881785478120313,0,0,8
13,Glycolysis and Gluconeogenesis WP534,0.015707380021833358,3.863275039745628,16.04659428796995,"['LDHA', 'TPI1', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'ALDOC', 'ENO2', 'ALDOA', 'GAPDH']",0.36126974050216726,0,0,10
14,Computational Model of Aerobic Glycolysis WP4629,0.01754906483669873,9.24170616113744,37.36195024402351,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH']",0.37479788472663716,0,0,6
15,VEGFA-VEGFR2 Signaling Pathway WP3888,0.020379394676763696,1.7920930799220274,6.9770322502263165,"['SET', 'CRIP2', 'FOXO4', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'RPL18A', 'ADAMTS1', 'TMSB4X', 'CFL1', 'AP2S1', 'PGK1', 'RPLP2', 'DNAJB9', 'ATP6V1E1', 'CCT7', 'TMSB10', 'SDF2L1', 'SSR4', 'NFATC2', 'DNAJA1', 'NR4A3', 'CYCS', 'RPL26', 'CALR', 'ALDOA', 'GAPDH', 'SLC25A11', 'EIF4G2', 'ARF6']",0.4062292672234897,0,0,31
16,Eukaryotic Transcription Initiation WP405,0.024369115466731674,inf,inf,"['TAF13', 'POLR2I', 'POLR3K', 'POLR2K']",0.4553978452845482,0,0,4
17,G13 Signaling Pathway WP524,0.038720138050985786,7.6892744479495265,25.000871963197195,"['CFL2', 'CFL1', 'ARHGDIG', 'CALM1', 'CALM2']",0.6093326988023553,0,0,5
18,Glycolysis in senescence WP5049,0.038720138050985786,7.6892744479495265,25.000871963197195,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'GAPDH']",0.6093326988023553,0,0,5
19,NO/cGMP/PKG mediated Neuroprotection WP4008,0.038720138050985786,7.6892744479495265,25.000871963197195,"['BAD', 'NEFL', 'CYCS', 'CALM1', 'CALM2']",0.6093326988023553,0,0,5
20,Calcium Regulation in the Cardiac Cell WP536,0.05233677900685337,2.424704276615105,7.153013214143765,"['RGS4', 'GJD2', 'GNG3', 'PRKAR1A', 'YWHAB', 'CHRM5', 'CALM3', 'CALR', 'CALM1', 'CALM2', 'YWHAH']",0.7559264927048011,0,0,11
21,Cell cycle WP179,0.05309182724682549,3.080824088748019,9.044474711148059,"['CDKN2D', 'PTTG1', 'GADD45B', 'GADD45A', 'YWHAB', 'SKP1', 'ANAPC11', 'YWHAH']",0.7559264927048011,0,0,8
22,HIF1A and PPARG regulation of glycolysis WP2456,0.06176592351025745,inf,inf,"['LDHA', 'TPI1', 'GAPDH']",0.8029570056333468,0,0,3
23,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.06176592351025745,inf,inf,"['MDH2', 'SCO2', 'HMGA1']",0.8029570056333468,0,0,3
24,Amyotrophic lateral sclerosis (ALS) WP2447,0.0834239674783681,6.141732283464567,15.254955214424564,"['BAD', 'NEFL', 'NEFH', 'SOD1']",0.9064969620447882,0,0,4
25,Synaptic Vesicle Pathway WP2267,0.0834239674783681,6.141732283464567,15.254955214424564,"['RAB3A', 'AP2S1', 'SLC25A4', 'AP2M1']",0.9064969620447882,0,0,4
26,Fragile X Syndrome  WP4549,0.0834239674783681,6.141732283464567,15.254955214424564,"['HOMER1', 'PRKAR1A', 'AP2S1', 'AP2M1']",0.9064969620447882,0,0,4
27,Adipogenesis WP236,0.08819856354502094,2.3095238095238093,5.607903962777278,"['SOCS3', 'CYP26B1', 'GADD45B', 'GADD45A', 'DDIT3', 'HMGA1', 'LPL', 'NDN', 'MIF']",0.9064969620447882,0,0,9
28,Pathways in clear cell renal cell carcinoma WP4018,0.09121637857377778,2.462123613312203,5.895606224932466,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOC', 'ENO2', 'ALDOA', 'GAPDH']",0.9064969620447882,0,0,8
29,Androgen receptor signaling pathway WP138,0.09338302810461994,2.6914556962025316,6.381564353486985,"['PRDX1', 'BAG1', 'STUB1', 'CALR', 'FKBP4', 'ETV5', 'RAN']",0.9064969620447882,0,0,7
30,EGF/EGFR signaling pathway WP437,0.09338302810461994,2.6914556962025316,6.381564353486985,"['NDUFA13', 'CFL1', 'STMN1', 'AP2S1', 'FOXO4', 'AP2M1', 'ARF6']",0.9064969620447882,0,0,7
31,Metabolic reprogramming in colon cancer WP4290,0.09398463486083089,3.074249605055292,7.269444302803543,"['LDHA', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'GAPDH']",0.9064969620447882,0,0,6
32,Selenium Micronutrient Network WP15,0.12521918021667588,1.9236883942766296,3.9968274385869287,"['SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'SELENOK', 'SEPHS2', 'SELENOH', 'SOD1', 'MSRB1']",0.9994920967597407,0,0,10
33,Airway smooth muscle cell contraction WP4962,0.15640288760180268,inf,inf,"['CALM1', 'CALM2']",0.9994920967597407,0,0,2
34,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.15640288760180268,inf,inf,"['COX8A', 'GSTP1']",0.9994920967597407,0,0,2
35,Base Excision Repair WP4752,0.15640288760180268,inf,inf,"['FEN1', 'POLE3']",0.9994920967597407,0,0,2
36,Fatty acid beta-oxidation WP143,0.15640288760180268,inf,inf,"['TPI1', 'LPL']",0.9994920967597407,0,0,2
37,mRNA Processing WP411,0.15640288760180268,inf,inf,"['SF3B5', 'SNU13']",0.9994920967597407,0,0,2
38,Nucleotide Excision Repair WP4753,0.15640288760180268,inf,inf,"['CETN2', 'POLE3']",0.9994920967597407,0,0,2
39,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.15640288760180268,inf,inf,"['PTTG1', 'ANAPC11']",0.9994920967597407,0,0,2
40,Melanoma WP4685,0.15835359362933543,2.3033175355450237,4.244841036257069,"['GADD45B', 'BAD', 'GADD45A', 'CALM3', 'CALM1', 'CALM2']",0.9994920967597407,0,0,6
41,DNA Repair Pathways Full Network WP4946,0.17283165134265793,3.0677165354330707,5.3851839459018755,"['FEN1', 'CENPX', 'CETN2', 'POLE3']",0.9994920967597407,0,0,4
42,Photodynamic therapy-induced unfolded protein response WP3613,0.17283165134265793,3.0677165354330707,5.3851839459018755,"['XBP1', 'DDIT3', 'DNAJB9', 'CALR']",0.9994920967597407,0,0,4
43,Regulation of Microtubule Cytoskeleton WP2038,0.17283165134265793,3.0677165354330707,5.3851839459018755,"['SPRED1', 'PARD6A', 'CFL2', 'STMN1']",0.9994920967597407,0,0,4
44,Cardiac Hypertrophic Response WP2795,0.1739563622317552,4.599056603773585,8.043523740178438,"['NFATC2', 'CALM1', 'CALM2']",0.9994920967597407,0,0,3
45,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.1739563622317552,4.599056603773585,8.043523740178438,"['CD63', 'CD81', 'SOD1']",0.9994920967597407,0,0,3
46,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.1739563622317552,4.599056603773585,8.043523740178438,"['LDHA', 'PKM', 'PGK1']",0.9994920967597407,0,0,3
47,Prostaglandin Synthesis and Regulation WP98,0.1739563622317552,4.599056603773585,8.043523740178438,"['HSD11B2', 'S100A6', 'PTGES']",0.9994920967597407,0,0,3
48,Myometrial relaxation and contraction pathways WP289,0.19868952395816694,1.5374800637958532,2.4845860079558704,"['RGS4', 'CREB3', 'GNG3', 'PRKAR1A', 'YWHAB', 'CRH', 'CALM3', 'IGFBP6', 'CALM1', 'CALM2', 'ACTG1', 'YWHAH']",0.9994920967597407,0,0,12
49,16p11.2 proximal deletion syndrome WP4949,0.28107667825685995,2.043044619422572,2.5928846629072506,"['ALDOA', 'SEZ6L2', 'CCT7', 'YPEL3']",0.9994920967597407,0,0,4
50,CAMKK2  Pathway WP4874,0.28107667825685995,2.043044619422572,2.5928846629072506,"['FIS1', 'NFATC2', 'CALM1', 'CALM2']",0.9994920967597407,0,0,4
51,Translation Factors WP107,0.28107667825685995,2.043044619422572,2.5928846629072506,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EIF1']",0.9994920967597407,0,0,4
52,Copper homeostasis WP3286,0.28107667825685995,2.043044619422572,2.5928846629072506,"['SCO2', 'COX17', 'ATOX1', 'SOD1']",0.9994920967597407,0,0,4
53,G Protein Signaling Pathways WP35,0.28107667825685995,2.043044619422572,2.5928846629072506,"['GNG3', 'PRKAR1A', 'CALM1', 'CALM2']",0.9994920967597407,0,0,4
54,Leptin signaling pathway WP2034,0.28107667825685995,2.043044619422572,2.5928846629072506,"['SOCS3', 'CISH', 'BAD', 'CFL2']",0.9994920967597407,0,0,4
55,Non-small cell lung cancer WP4255,0.28107667825685995,2.043044619422572,2.5928846629072506,"['GADD45B', 'BAD', 'GADD45A', 'CYCS']",0.9994920967597407,0,0,4
56,Proteasome Degradation WP183,0.28107667825685995,2.043044619422572,2.5928846629072506,"['PSMD8', 'PSMB6', 'H2AFZ', 'PSMB10']",0.9994920967597407,0,0,4
57,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.28107667825685995,2.043044619422572,2.5928846629072506,"['CREB3', 'CALM3', 'CALM1', 'CALM2']",0.9994920967597407,0,0,4
58,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.3097549157946273,2.297169811320755,2.6922230360846435,"['NFATC2', 'CALM1', 'CALM2']",0.9994920967597407,0,0,3
59,Common Pathways Underlying Drug Addiction WP2636,0.3097549157946273,2.297169811320755,2.6922230360846435,"['CALM1', 'CALM2', 'ACTG1']",0.9994920967597407,0,0,3
60,Ectoderm Differentiation WP2858,0.3097549157946273,2.297169811320755,2.6922230360846435,"['ARHGDIG', 'JAKMIP1', 'LY6E']",0.9994920967597407,0,0,3
61,Glycogen Synthesis and Degradation WP500,0.3097549157946273,2.297169811320755,2.6922230360846435,"['CALM3', 'CALM1', 'CALM2']",0.9994920967597407,0,0,3
62,IL-6 signaling pathway WP364,0.3097549157946273,2.297169811320755,2.6922230360846435,"['SOCS3', 'BAD', 'NR2F6']",0.9994920967597407,0,0,3
63,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.3097549157946273,2.297169811320755,2.6922230360846435,"['CISH', 'CALM1', 'CALM2']",0.9994920967597407,0,0,3
64,Serotonin and anxiety WP3947,0.3456766862968788,3.061224489795918,3.2517899187145725,"['POMC', 'CRH']",0.9994920967597407,0,0,2
65,ACE Inhibitor Pathway WP554,0.3456766862968788,3.061224489795918,3.2517899187145725,"['MAS1', 'ATP6AP2']",0.9994920967597407,0,0,2
66,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.3456766862968788,3.061224489795918,3.2517899187145725,"['XBP1', 'DDIT3']",0.9994920967597407,0,0,2
67,Endothelin Pathways WP2197,0.3456766862968788,3.061224489795918,3.2517899187145725,"['CALM1', 'CALM2']",0.9994920967597407,0,0,2
68,GABA receptor Signaling WP4159,0.3456766862968788,3.061224489795918,3.2517899187145725,"['AP2S1', 'AP2M1']",0.9994920967597407,0,0,2
69,Histone Modifications WP2369,0.3456766862968788,3.061224489795918,3.2517899187145725,"['SET', 'HIST1H3E']",0.9994920967597407,0,0,2
70,Joubert Syndrome WP4656,0.3456766862968788,3.061224489795918,3.2517899187145725,"['CETN2', 'ARL2']",0.9994920967597407,0,0,2
71,Melatonin metabolism and effects WP3298,0.3456766862968788,3.061224489795918,3.2517899187145725,"['CALM1', 'CALM2']",0.9994920967597407,0,0,2
72,Nanomaterial induced apoptosis WP2507,0.3456766862968788,3.061224489795918,3.2517899187145725,"['ENDOG', 'CYCS']",0.9994920967597407,0,0,2
73,Nephrotic syndrome WP4758,0.3456766862968788,3.061224489795918,3.2517899187145725,"['MYO1E', 'ARHGDIA']",0.9994920967597407,0,0,2
74,Nucleotide metabolism WP404,0.3456766862968788,3.061224489795918,3.2517899187145725,"['NME2', 'OAZ1']",0.9994920967597407,0,0,2
75,One-carbon metabolism and related pathways WP3940,0.3456766862968788,3.061224489795918,3.2517899187145725,"['GPX4', 'SOD1']",0.9994920967597407,0,0,2
76,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.3456766862968788,3.061224489795918,3.2517899187145725,"['LPL', 'FOXO4']",0.9994920967597407,0,0,2
77,Parkinson's disease pathway WP2371,0.3456766862968788,3.061224489795918,3.2517899187145725,"['PINK1', 'CYCS']",0.9994920967597407,0,0,2
78,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.3456766862968788,3.061224489795918,3.2517899187145725,"['BAD', 'FOXO4']",0.9994920967597407,0,0,2
79,Integrated breast cancer pathway WP1984,0.35572485495177086,1.5315457413249212,1.5830021959644556,"['GADD45A', 'BAD', 'PHB', 'FAU', 'JAKMIP1']",0.9994920967597407,0,0,5
80,Ras signaling WP4223,0.37636288009013835,1.3401898734177216,1.3096355470641172,"['GNG3', 'BAD', 'CALM3', 'FOXO4', 'CALM1', 'CALM2', 'ARF6']",0.9994920967597407,0,0,7
81,Regulation of Actin Cytoskeleton WP51,0.37636288009013835,1.3401898734177216,1.3096355470641172,"['FGF17', 'CFL2', 'TMSB4X', 'CHRM5', 'CFL1', 'BRK1', 'ACTG1']",0.9994920967597407,0,0,7
82,Statin inhibition of cholesterol production WP430,0.3956654724679593,inf,inf,['LPL'],0.9994920967597407,0,0,1
83,Tamoxifen metabolism WP691,0.3956654724679593,inf,inf,['CYP2A6'],0.9994920967597407,0,0,1
84,Autophagy WP4923,0.3956654724679593,inf,inf,['ATG101'],0.9994920967597407,0,0,1
85,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.3956654724679593,inf,inf,['MDH2'],0.9994920967597407,0,0,1
86,Triacylglyceride synthesis WP325,0.3956654724679593,inf,inf,['LPL'],0.9994920967597407,0,0,1
87,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.3956654724679593,inf,inf,['CCK'],0.9994920967597407,0,0,1
88,"Cerebral organic acidurias, including diseases WP4519",0.3956654724679593,inf,inf,['MDH2'],0.9994920967597407,0,0,1
89,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.3956654724679593,inf,inf,['DHCR24'],0.9994920967597407,0,0,1
90,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.3956654724679593,inf,inf,['DHCR24'],0.9994920967597407,0,0,1
91,Urea cycle and associated pathways WP4595,0.3956654724679593,inf,inf,['MDH2'],0.9994920967597407,0,0,1
92,Valproic acid pathway WP3871,0.3956654724679593,inf,inf,['CYP2A6'],0.9994920967597407,0,0,1
93,Composition of Lipid Particles WP3601,0.3956654724679593,inf,inf,['LPL'],0.9994920967597407,0,0,1
94,DNA Mismatch Repair WP531,0.3956654724679593,inf,inf,['POLE3'],0.9994920967597407,0,0,1
95,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.3956654724679593,inf,inf,['HIST1H3E'],0.9994920967597407,0,0,1
96,Eicosanoid Synthesis WP167,0.3956654724679593,inf,inf,['PTGES'],0.9994920967597407,0,0,1
97,Gastric Cancer Network 2 WP2363,0.3956654724679593,inf,inf,['S100A6'],0.9994920967597407,0,0,1
98,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.3956654724679593,inf,inf,['LDHA'],0.9994920967597407,0,0,1
99,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.3956654724679593,inf,inf,['ELOB'],0.9994920967597407,0,0,1
100,Lipid Metabolism Pathway WP3965,0.3956654724679593,inf,inf,['PRKAR1A'],0.9994920967597407,0,0,1
101,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.3956654724679593,inf,inf,['SOCS3'],0.9994920967597407,0,0,1
102,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.3956654724679593,inf,inf,['LPL'],0.9994920967597407,0,0,1
103,miRNA Biogenesis WP2338,0.3956654724679593,inf,inf,['RAN'],0.9994920967597407,0,0,1
104,Mitochondrial CII Assembly WP4920,0.3956654724679593,inf,inf,['SDHAF1'],0.9994920967597407,0,0,1
105,MTHFR deficiency WP4288,0.3956654724679593,inf,inf,['CYCS'],0.9994920967597407,0,0,1
106,Nicotine Metabolism WP1600,0.3956654724679593,inf,inf,['CYP2A6'],0.9994920967597407,0,0,1
107,Osteoclast Signaling WP12,0.3956654724679593,inf,inf,['ATP6V1G1'],0.9994920967597407,0,0,1
108,SARS-CoV-2 mitochondrial interactions WP5038,0.3956654724679593,inf,inf,['PHB'],0.9994920967597407,0,0,1
109,Male infertility WP4673,0.39569996721030737,1.5307086614173229,1.4191184898882367,"['CYP26B1', 'DND1', 'HMGA1', 'ETV5']",0.9994920967597407,0,0,4
110,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.44667811019859577,1.529874213836478,1.2329517212198922,"['POMC', 'CREB3', 'BAD']",0.9994920967597407,0,0,3
111,Endochondral Ossification with Skeletal Dysplasias WP4808,0.44667811019859577,1.529874213836478,1.2329517212198922,"['ADAMTS1', 'CALM1', 'CALM2']",0.9994920967597407,0,0,3
112,Endochondral Ossification WP474,0.44667811019859577,1.529874213836478,1.2329517212198922,"['ADAMTS1', 'CALM1', 'CALM2']",0.9994920967597407,0,0,3
113,Notch Signaling Pathway Netpath WP61,0.44667811019859577,1.529874213836478,1.2329517212198922,"['PSENEN', 'SKP1', 'DLL3']",0.9994920967597407,0,0,3
114,Oxidative Damage WP3941,0.44667811019859577,1.529874213836478,1.2329517212198922,"['BAD', 'GADD45A', 'CYCS']",0.9994920967597407,0,0,3
115,Small cell lung cancer WP4658,0.45523029603631016,1.2749737118822293,1.0033429122717425,"['LAMB3', 'GADD45B', 'GADD45A', 'CYCS', 'SKP1']",0.9994920967597407,0,0,5
116,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5066284908776807,1.2233070866141733,0.8318210542314048,"['GADD45B', 'BAD', 'GADD45A', 'CYCS']",0.9994920967597407,0,0,4
117,DNA damage response WP707,0.5066284908776807,1.2233070866141733,0.8318210542314048,"['GADD45B', 'CDK5', 'GADD45A', 'CYCS']",0.9994920967597407,0,0,4
118,miRNA regulation of DNA damage response WP1530,0.5066284908776807,1.2233070866141733,0.8318210542314048,"['GADD45B', 'CDK5', 'GADD45A', 'CYCS']",0.9994920967597407,0,0,4
119,16p11.2 distal deletion syndrome WP4950,0.517396873649073,1.5290423861852434,1.007554914176437,"['CD81', 'NFATC2']",0.9994920967597407,0,0,2
120,Unfolded protein response WP4925,0.517396873649073,1.5290423861852434,1.007554914176437,"['XBP1', 'DDIT3']",0.9994920967597407,0,0,2
121,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.517396873649073,1.5290423861852434,1.007554914176437,"['CFL1', 'BANF1']",0.9994920967597407,0,0,2
122,Imatinib and Chronic Myeloid Leukemia WP3640,0.517396873649073,1.5290423861852434,1.007554914176437,"['SPRED2', 'GADD45A']",0.9994920967597407,0,0,2
123,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.517396873649073,1.5290423861852434,1.007554914176437,"['SUPT4H1', 'NFATC2']",0.9994920967597407,0,0,2
124,Intraflagellar transport proteins binding to dynein WP4532,0.517396873649073,1.5290423861852434,1.007554914176437,"['DYNLRB1', 'DYNLL1']",0.9994920967597407,0,0,2
125,Oxidation by Cytochrome P450 WP43,0.517396873649073,1.5290423861852434,1.007554914176437,"['CYP26B1', 'CYP2A6']",0.9994920967597407,0,0,2
126,Physiological and pathological hypertrophy of the heart WP1528,0.517396873649073,1.5290423861852434,1.007554914176437,"['CALM1', 'CALM2']",0.9994920967597407,0,0,2
127,PPAR signaling pathway WP3942,0.517396873649073,1.5290423861852434,1.007554914176437,"['FABP7', 'LPL']",0.9994920967597407,0,0,2
128,Retinoblastoma gene in cancer WP2446,0.517396873649073,1.5290423861852434,1.007554914176437,"['H2AFZ', 'STMN1']",0.9994920967597407,0,0,2
129,Apoptosis Modulation and Signaling WP1772,0.549790591054561,1.0917079765660207,0.6530791623179273,"['ENDOG', 'CAPNS1', 'BIK', 'BAD', 'CYCS']",0.9994920967597407,0,0,5
130,Acute viral myocarditis WP4298,0.5708790957226593,1.1462264150943395,0.6425491199442636,"['ENDOG', 'CYCS', 'EIF4G2']",0.9994920967597407,0,0,3
131,Amino Acid metabolism WP3925,0.5708790957226593,1.1462264150943395,0.6425491199442636,"['LDHA', 'PKM', 'MDH2']",0.9994920967597407,0,0,3
132,Cytosolic DNA-sensing pathway WP4655,0.5708790957226593,1.1462264150943395,0.6425491199442636,"['POLR3K', 'POLR2K', 'POLR2L']",0.9994920967597407,0,0,3
133,G1 to S cell cycle control WP45,0.5708790957226593,1.1462264150943395,0.6425491199442636,"['CDKN2D', 'CREB3', 'GADD45A']",0.9994920967597407,0,0,3
134,Genotoxicity pathway WP4286,0.5708790957226593,1.1462264150943395,0.6425491199442636,"['RPS27', 'GADD45A', 'TRIAP1']",0.9994920967597407,0,0,3
135,IL-18 signaling pathway WP4754,0.5967699141286763,0.9713454545454545,0.5014314894931219,"['MTCH1', 'NRN1', 'IMP3', 'CD81', 'BAD', 'COX17', 'NDUFC1', 'SOCS3', 'ARL4D', 'TMSB4X', 'STMN1', 'CYCS', 'ITM2C', 'ARF6']",0.9994920967597407,0,0,14
136,Serotonin and anxiety-related events WP3944,0.6349277443418614,1.5282131661442007,0.6941817760608278,['CRH'],0.9994920967597407,0,0,1
137,Alpha 6 Beta 4 signaling pathway WP244,0.6349277443418614,1.5282131661442007,0.6941817760608278,['LAMB3'],0.9994920967597407,0,0,1
138,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.6349277443418614,1.5282131661442007,0.6941817760608278,['DLL3'],0.9994920967597407,0,0,1
139,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.6349277443418614,1.5282131661442007,0.6941817760608278,['LPL'],0.9994920967597407,0,0,1
140,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.6349277443418614,1.5282131661442007,0.6941817760608278,['LPL'],0.9994920967597407,0,0,1
141,BDNF-TrkB Signaling WP3676,0.6349277443418614,1.5282131661442007,0.6941817760608278,['HOMER1'],0.9994920967597407,0,0,1
142,Cannabinoid receptor signaling WP3869,0.6349277443418614,1.5282131661442007,0.6941817760608278,['PRKAR1A'],0.9994920967597407,0,0,1
143,TP53 network WP1742,0.6349277443418614,1.5282131661442007,0.6941817760608278,['GADD45A'],0.9994920967597407,0,0,1
144,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6349277443418614,1.5282131661442007,0.6941817760608278,['EIF4A2'],0.9994920967597407,0,0,1
145,Type 2 papillary renal cell carcinoma WP4241,0.6349277443418614,1.5282131661442007,0.6941817760608278,['ELOB'],0.9994920967597407,0,0,1
146,Type II interferon signaling (IFNG) WP619,0.6349277443418614,1.5282131661442007,0.6941817760608278,['SOCS3'],0.9994920967597407,0,0,1
147,Wnt Signaling Pathway WP363,0.6349277443418614,1.5282131661442007,0.6941817760608278,['NFATC2'],0.9994920967597407,0,0,1
148,DNA Replication WP466,0.6349277443418614,1.5282131661442007,0.6941817760608278,['UBA52'],0.9994920967597407,0,0,1
149,Dopamine metabolism WP2436,0.6349277443418614,1.5282131661442007,0.6941817760608278,['SOD1'],0.9994920967597407,0,0,1
150,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.6349277443418614,1.5282131661442007,0.6941817760608278,['PTGES'],0.9994920967597407,0,0,1
151,EPO Receptor Signaling WP581,0.6349277443418614,1.5282131661442007,0.6941817760608278,['CISH'],0.9994920967597407,0,0,1
152,Fatty Acid Omega Oxidation WP206,0.6349277443418614,1.5282131661442007,0.6941817760608278,['CYP2A6'],0.9994920967597407,0,0,1
153,Fatty acid transporters WP5061,0.6349277443418614,1.5282131661442007,0.6941817760608278,['FABP7'],0.9994920967597407,0,0,1
154,Fluoropyrimidine Activity WP1601,0.6349277443418614,1.5282131661442007,0.6941817760608278,['CYP2A6'],0.9994920967597407,0,0,1
155,Genes related to primary cilium development (based on CRISPR) WP4536,0.6349277443418614,1.5282131661442007,0.6941817760608278,['DYNLL1'],0.9994920967597407,0,0,1
156,Glutathione metabolism WP100,0.6349277443418614,1.5282131661442007,0.6941817760608278,['GPX4'],0.9994920967597407,0,0,1
157,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6349277443418614,1.5282131661442007,0.6941817760608278,['BAD'],0.9994920967597407,0,0,1
158,Integrin-mediated Cell Adhesion WP185,0.6349277443418614,1.5282131661442007,0.6941817760608278,['CAPNS1'],0.9994920967597407,0,0,1
159,Interferon type I signaling pathways WP585,0.6349277443418614,1.5282131661442007,0.6941817760608278,['SOCS3'],0.9994920967597407,0,0,1
160,Iron metabolism in placenta WP2007,0.6349277443418614,1.5282131661442007,0.6941817760608278,['FTH1'],0.9994920967597407,0,0,1
161,Leptin Insulin Overlap WP3935,0.6349277443418614,1.5282131661442007,0.6941817760608278,['SOCS3'],0.9994920967597407,0,0,1
162,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.6349277443418614,1.5282131661442007,0.6941817760608278,['ATG101'],0.9994920967597407,0,0,1
163,Notch Signaling WP268,0.6349277443418614,1.5282131661442007,0.6941817760608278,['DLL3'],0.9994920967597407,0,0,1
164,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.6349277443418614,1.5282131661442007,0.6941817760608278,['EIF1'],0.9994920967597407,0,0,1
165,Nuclear receptors WP170,0.6349277443418614,1.5282131661442007,0.6941817760608278,['NR2F6'],0.9994920967597407,0,0,1
166,Purine metabolism and related disorders WP4224,0.6349277443418614,1.5282131661442007,0.6941817760608278,['APRT'],0.9994920967597407,0,0,1
167,Purine metabolism WP4792,0.6349277443418614,1.5282131661442007,0.6941817760608278,['APRT'],0.9994920967597407,0,0,1
168,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.6349277443418614,1.5282131661442007,0.6941817760608278,['MAS1'],0.9994920967597407,0,0,1
169,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6355319309366745,0.9542586750788643,0.43255872439165577,"['TMSB4X', 'NEFL', 'NEFH', 'PFN2', 'SOD1']",0.9994920967597407,0,0,5
170,7-oxo-C and 7beta-HC pathways WP5064,0.6558247075505242,1.0183150183150182,0.4295881453375907,"['HSD11B2', 'THEM5']",0.9994920967597407,0,0,2
171,Aryl Hydrocarbon Receptor Netpath WP2586,0.6558247075505242,1.0183150183150182,0.4295881453375907,"['AIP', 'LPL']",0.9994920967597407,0,0,2
172,B Cell Receptor Signaling Pathway WP23,0.6558247075505242,1.0183150183150182,0.4295881453375907,"['CD81', 'NFATC2']",0.9994920967597407,0,0,2
173,Thermogenesis WP4321,0.6558247075505242,1.0183150183150182,0.4295881453375907,"['CREB3', 'ACTG1']",0.9994920967597407,0,0,2
174,Cardiac Progenitor Differentiation WP2406,0.6558247075505242,1.0183150183150182,0.4295881453375907,"['MESP1', 'THY1']",0.9994920967597407,0,0,2
175,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6558247075505242,1.0183150183150182,0.4295881453375907,"['H2AFZ', 'HIST1H3E']",0.9994920967597407,0,0,2
176,IL-2 signaling pathway WP49,0.6558247075505242,1.0183150183150182,0.4295881453375907,"['SOCS3', 'CISH']",0.9994920967597407,0,0,2
177,IL-3 signaling pathway WP286,0.6558247075505242,1.0183150183150182,0.4295881453375907,"['YWHAB', 'BAD']",0.9994920967597407,0,0,2
178,MET in type 1 papillary renal cell carcinoma WP4205,0.6558247075505242,1.0183150183150182,0.4295881453375907,"['BAD', 'RPL11']",0.9994920967597407,0,0,2
179,Pre-implantation embryo WP3527,0.6558247075505242,1.0183150183150182,0.4295881453375907,"['DDIT3', 'HMGA1']",0.9994920967597407,0,0,2
180,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6558247075505242,1.0183150183150182,0.4295881453375907,"['SOCS3', 'STMN1']",0.9994920967597407,0,0,2
181,AGE/RAGE pathway WP2324,0.6759864731811476,0.9160377358490566,0.35870408400270803,"['CYCS', 'FOXO4', 'SOD1']",0.9994920967597407,0,0,3
182,Endometrial cancer WP4155,0.6759864731811476,0.9160377358490566,0.35870408400270803,"['GADD45B', 'BAD', 'GADD45A']",0.9994920967597407,0,0,3
183,Pancreatic adenocarcinoma pathway WP4263,0.6759864731811476,0.9160377358490566,0.35870408400270803,"['GADD45B', 'BAD', 'GADD45A']",0.9994920967597407,0,0,3
184,Prader-Willi and Angelman Syndrome WP3998,0.6759864731811476,0.9160377358490566,0.35870408400270803,"['POMC', 'PCSK1', 'NDN']",0.9994920967597407,0,0,3
185,Senescence and Autophagy in Cancer WP615,0.6940882118165049,0.8719910011248594,0.3184129380094205,"['GABARAPL2', 'GABARAPL1', 'HMGA1', 'GABARAP']",0.9994920967597407,0,0,4
186,Complement system WP2806,0.6940882118165049,0.8719910011248594,0.3184129380094205,"['FKBP2', 'RPS19', 'CD59', 'CALR']",0.9994920967597407,0,0,4
187,Exercise-induced Circadian Regulation WP410,0.6940882118165049,0.8719910011248594,0.3184129380094205,"['DNAJA1', 'HSPA8', 'GSTP1', 'EIF4G2']",0.9994920967597407,0,0,4
188,Focal Adhesion WP306,0.6940882118165049,0.8719910011248594,0.3184129380094205,"['LAMB3', 'BAD', 'MYL12B', 'ACTG1']",0.9994920967597407,0,0,4
189,Apoptosis WP254,0.7603978670858582,0.7629513343799058,0.20898265000576272,"['BAD', 'CYCS']",0.9994920967597407,0,0,2
190,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7603978670858582,0.7629513343799058,0.20898265000576272,"['CYCS', 'ACTG1']",0.9994920967597407,0,0,2
191,Ferroptosis WP4313,0.7603978670858582,0.7629513343799058,0.20898265000576272,"['GPX4', 'FTH1']",0.9994920967597407,0,0,2
192,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.7603978670858582,0.7629513343799058,0.20898265000576272,"['RAB3A', 'NEFL']",0.9994920967597407,0,0,2
193,Modulators of TCR signaling and T cell activation WP5072,0.7603978670858582,0.7629513343799058,0.20898265000576272,"['NDUFB10', 'ELOB']",0.9994920967597407,0,0,2
194,22q11.2 copy number variation syndrome WP4657,0.7606653579735847,0.7625786163522013,0.20861234666239187,"['CYP26B1', 'MRPL40', 'RAN']",0.9994920967597407,0,0,3
195,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.7606653579735847,0.7625786163522013,0.20861234666239187,"['NFATC2', 'CALM1', 'CALM2']",0.9994920967597407,0,0,3
196,Insulin Signaling WP481,0.7606653579735847,0.7625786163522013,0.20861234666239187,"['SOCS3', 'XBP1', 'ARF6']",0.9994920967597407,0,0,3
197,Hepatitis B infection WP4666,0.7736468321503105,0.7618296529968455,0.19551580881584213,"['CREB3', 'YWHAB', 'BAD', 'NFATC2', 'CYCS']",0.9994920967597407,0,0,5
198,NRF2 pathway WP2884,0.7736468321503105,0.7618296529968455,0.19551580881584213,"['CYP2A6', 'FTH1', 'PRDX1', 'GSTP1', 'SLC5A3']",0.9994920967597407,0,0,5
199,Apoptosis Modulation by HSP70 WP384,0.7795530357107587,0.7633228840125392,0.19009377449989778,['CYCS'],0.9994920967597407,0,0,1
200,Striated Muscle Contraction Pathway WP383,0.7795530357107587,0.7633228840125392,0.19009377449989778,['ACTG1'],0.9994920967597407,0,0,1
201,Sulfation Biotransformation Reaction WP692,0.7795530357107587,0.7633228840125392,0.19009377449989778,['SULT4A1'],0.9994920967597407,0,0,1
202,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.7795530357107587,0.7633228840125392,0.19009377449989778,['ACTG1'],0.9994920967597407,0,0,1
203,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7795530357107587,0.7633228840125392,0.19009377449989778,['HOMER1'],0.9994920967597407,0,0,1
204,Blood Clotting Cascade WP272,0.7795530357107587,0.7633228840125392,0.19009377449989778,['F8A1'],0.9994920967597407,0,0,1
205,Cancer immunotherapy by PD-1 blockade WP4585,0.7795530357107587,0.7633228840125392,0.19009377449989778,['NFATC2'],0.9994920967597407,0,0,1
206,Canonical and non-canonical Notch signaling WP3845,0.7795530357107587,0.7633228840125392,0.19009377449989778,['DLL3'],0.9994920967597407,0,0,1
207,Transcriptional cascade regulating adipogenesis WP4211,0.7795530357107587,0.7633228840125392,0.19009377449989778,['DDIT3'],0.9994920967597407,0,0,1
208,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.7795530357107587,0.7633228840125392,0.19009377449989778,['HSD11B2'],0.9994920967597407,0,0,1
209,Constitutive Androstane Receptor Pathway WP2875,0.7795530357107587,0.7633228840125392,0.19009377449989778,['CYP2A6'],0.9994920967597407,0,0,1
210,Vitamin D-sensitive calcium signaling in depression WP4698,0.7795530357107587,0.7633228840125392,0.19009377449989778,['GPX4'],0.9994920967597407,0,0,1
211,White fat cell differentiation WP4149,0.7795530357107587,0.7633228840125392,0.19009377449989778,['DDIT3'],0.9994920967597407,0,0,1
212,Disruption of postsynaptic signaling by CNV WP4875,0.7795530357107587,0.7633228840125392,0.19009377449989778,['HOMER1'],0.9994920967597407,0,0,1
213,DNA IR-damage and cellular response via ATR WP4016,0.7795530357107587,0.7633228840125392,0.19009377449989778,['FEN1'],0.9994920967597407,0,0,1
214,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7795530357107587,0.7633228840125392,0.19009377449989778,['CDK5'],0.9994920967597407,0,0,1
215,Dual hijack model of Vif in HIV infection WP3300,0.7795530357107587,0.7633228840125392,0.19009377449989778,['ELOB'],0.9994920967597407,0,0,1
216,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7795530357107587,0.7633228840125392,0.19009377449989778,['BAD'],0.9994920967597407,0,0,1
217,Gastric acid production WP2596,0.7795530357107587,0.7633228840125392,0.19009377449989778,['CCK'],0.9994920967597407,0,0,1
218,Genes targeted by miRNAs in adipocytes WP1992,0.7795530357107587,0.7633228840125392,0.19009377449989778,['TMSB4X'],0.9994920967597407,0,0,1
219,Hippo-Merlin Signaling Dysregulation WP4541,0.7795530357107587,0.7633228840125392,0.19009377449989778,['PRKAR1A'],0.9994920967597407,0,0,1
220,Interleukin-11 Signaling Pathway WP2332,0.7795530357107587,0.7633228840125392,0.19009377449989778,['SOCS3'],0.9994920967597407,0,0,1
221,Kit receptor signaling pathway WP304,0.7795530357107587,0.7633228840125392,0.19009377449989778,['BAD'],0.9994920967597407,0,0,1
222,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7795530357107587,0.7633228840125392,0.19009377449989778,['ACTG1'],0.9994920967597407,0,0,1
223,Nicotine Activity on Dopaminergic Neurons WP1602,0.7795530357107587,0.7633228840125392,0.19009377449989778,['CDK5'],0.9994920967597407,0,0,1
224,NOTCH1 regulation of endothelial cell calcification WP3413,0.7795530357107587,0.7633228840125392,0.19009377449989778,['DLL3'],0.9994920967597407,0,0,1
225,p38 MAPK Signaling Pathway WP400,0.7795530357107587,0.7633228840125392,0.19009377449989778,['DDIT3'],0.9994920967597407,0,0,1
226,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7795530357107587,0.7633228840125392,0.19009377449989778,['LDHA'],0.9994920967597407,0,0,1
227,Pregnane X receptor pathway WP2876,0.7795530357107587,0.7633228840125392,0.19009377449989778,['CYP2A6'],0.9994920967597407,0,0,1
228,Circadian rhythm related genes WP3594,0.7978844788662184,0.7606973058637084,0.17175895176197076,"['HOMER1', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'SKP1', 'NR2F6', 'HCRTR1']",0.9994920967597407,0,0,8
229,Metapathway biotransformation Phase I and II WP702,0.8257449930515129,0.6918554631488385,0.1324690661795238,"['CYP26B1', 'CYP2A6', 'GPX4', 'GSTP1', 'SULT4A1']",0.9994920967597407,0,0,5
230,3q29 copy number variation syndrome WP4906,0.8362052364277439,0.6097331240188383,0.10906979162858955,"['DYNLRB1', 'DYNLL1']",0.9994920967597407,0,0,2
231,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8362052364277439,0.6097331240188383,0.10906979162858955,"['BEX3', 'SOCS3']",0.9994920967597407,0,0,2
232,Vitamin A and carotenoid metabolism WP716,0.8362052364277439,0.6097331240188383,0.10906979162858955,"['CYP26B1', 'LPL']",0.9994920967597407,0,0,2
233,DNA damage response (only ATM dependent) WP710,0.8362052364277439,0.6097331240188383,0.10906979162858955,"['BIK', 'BAD']",0.9994920967597407,0,0,2
234,Ebola Virus Pathway on Host WP4217,0.8362052364277439,0.6097331240188383,0.10906979162858955,"['SOCS3', 'ACTG1']",0.9994920967597407,0,0,2
235,Folate Metabolism WP176,0.8362052364277439,0.6097331240188383,0.10906979162858955,"['GPX4', 'SOD1']",0.9994920967597407,0,0,2
236,IL-4 signaling pathway WP395,0.8362052364277439,0.6097331240188383,0.10906979162858955,"['SOCS3', 'BAD']",0.9994920967597407,0,0,2
237,Mesodermal commitment pathway WP2857,0.8362052364277439,0.6097331240188383,0.10906979162858955,"['PRKAR1A', 'RPL38']",0.9994920967597407,0,0,2
238,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8362052364277439,0.6097331240188383,0.10906979162858955,"['BAD', 'STMN1']",0.9994920967597407,0,0,2
239,ATM Signaling Network in Development and Disease  WP3878,0.8669382154112041,0.5083594566353187,0.07258741009761666,['CDK5'],0.9994920967597407,0,0,1
240,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8669382154112041,0.5083594566353187,0.07258741009761666,['CISH'],0.9994920967597407,0,0,1
241,Vitamin B12 metabolism WP1533,0.8669382154112041,0.5083594566353187,0.07258741009761666,['SOD1'],0.9994920967597407,0,0,1
242,Galanin receptor pathway WP4970,0.8669382154112041,0.5083594566353187,0.07258741009761666,['POMC'],0.9994920967597407,0,0,1
243,Heart Development WP1591,0.8669382154112041,0.5083594566353187,0.07258741009761666,['NFATC2'],0.9994920967597407,0,0,1
244,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8669382154112041,0.5083594566353187,0.07258741009761666,['DDIT3'],0.9994920967597407,0,0,1
245,Hypertrophy Model WP516,0.8669382154112041,0.5083594566353187,0.07258741009761666,['NR4A3'],0.9994920967597407,0,0,1
246,IL-7 signaling pathway WP205,0.8669382154112041,0.5083594566353187,0.07258741009761666,['BAD'],0.9994920967597407,0,0,1
247,Integrated Cancer Pathway WP1971,0.8669382154112041,0.5083594566353187,0.07258741009761666,['BAD'],0.9994920967597407,0,0,1
248,Oxidative Stress WP408,0.8669382154112041,0.5083594566353187,0.07258741009761666,['SOD1'],0.9994920967597407,0,0,1
249,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.8676501999544544,0.6513202437373053,0.09246574721246688,"['PRKAR1A', 'YWHAB', 'ALDOA', 'GAPDH', 'SLC25A4', 'YWHAH']",0.9994920967597407,0,0,6
250,Breast cancer pathway WP4262,0.8676501999544544,0.6513202437373053,0.09246574721246688,"['FGF17', 'FRAT2', 'GADD45B', 'GADD45A', 'SKP1', 'DLL3']",0.9994920967597407,0,0,6
251,TGF-beta Signaling Pathway WP366,0.8760482953396636,0.5707547169811321,0.07553028776319838,"['PARD6A', 'CITED1', 'SKP1']",0.9994920967597407,0,0,3
252,Wnt signaling WP428,0.8760482953396636,0.5707547169811321,0.07553028776319838,"['FRAT2', 'SFRP2', 'NFATC2']",0.9994920967597407,0,0,3
253,Sleep regulation WP3591,0.8896113539361674,0.5075876504447933,0.05937282826869046,"['CRH', 'HCRTR1']",0.9994920967597407,0,0,2
254,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8896113539361674,0.5075876504447933,0.05937282826869046,"['CLDN9', 'DLL3']",0.9994920967597407,0,0,2
255,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9049178720526179,0.5526127415891195,0.05521214053848252,"['PSMD8', 'HSPA8', 'TUBA1A', 'STUB1']",0.9994920967597407,0,0,4
256,Proximal tubule transport WP4917,0.9126519741667963,0.5068134171907757,0.046323081010951624,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1F']",0.9994920967597407,0,0,3
257,Aryl Hydrocarbon Receptor Pathway WP2873,0.9197164028367711,0.38087774294670845,0.031875625645559784,['AIP'],0.9994920967597407,0,0,1
258,Ciliopathies WP4803,0.9197164028367711,0.38087774294670845,0.031875625645559784,['NEK2'],0.9994920967597407,0,0,1
259,IL-5 signaling pathway WP127,0.9197164028367711,0.38087774294670845,0.031875625645559784,['SPRED1'],0.9994920967597407,0,0,1
260,miRNA regulation of prostate cancer signaling pathways WP3981,0.9197164028367711,0.38087774294670845,0.031875625645559784,['BAD'],0.9994920967597407,0,0,1
261,Monoamine GPCRs WP58,0.9197164028367711,0.38087774294670845,0.031875625645559784,['CHRM5'],0.9994920967597407,0,0,1
262,Neural Crest Differentiation WP2064,0.9197164028367711,0.38087774294670845,0.031875625645559784,['DLL3'],0.9994920967597407,0,0,1
263,Oxysterols derived from cholesterol WP4545,0.9197164028367711,0.38087774294670845,0.031875625645559784,['THEM5'],0.9994920967597407,0,0,1
264,Pathways Regulating Hippo Signaling WP4540,0.9197164028367711,0.38087774294670845,0.031875625645559784,['PRKAR1A'],0.9994920967597407,0,0,1
265,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.9197164028367711,0.38087774294670845,0.031875625645559784,['GSTP1'],0.9994920967597407,0,0,1
266,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9234033325746674,0.5687203791469194,0.04532084922636801,"['FGF17', 'CREB3', 'GNG3', 'LAMB3', 'BAD', 'PELO']",0.9994920967597407,0,0,6
267,Endoderm differentiation WP2853,0.9264529351714883,0.434626597891904,0.033202009437834995,"['TCEAL2', 'NME1']",0.9994920967597407,0,0,2
268,Vitamin D Receptor Pathway WP2877,0.9426106567641973,0.534708670197937,0.0316023298197532,"['CDKN2D', 'COLEC11', 'GADD45A', 'DND1', 'S100A6', 'NFATC2']",0.9994920967597407,0,0,6
269,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9508907965925557,0.46662628709872805,0.023497458096440205,"['RAB3A', 'CDK5', 'BAD', 'CFL1']",0.9994920967597407,0,0,4
270,Corticotropin-releasing hormone signaling pathway WP2355,0.9514603193492255,0.37990580847723704,0.01890308590674486,"['POMC', 'CRH']",0.9994920967597407,0,0,2
271,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9514603193492255,0.37990580847723704,0.01890308590674486,"['FRAT2', 'SFRP2']",0.9994920967597407,0,0,2
272,Pathogenic Escherichia coli infection WP2272,0.9514603193492255,0.37990580847723704,0.01890308590674486,"['TUBA1A', 'ACTG1']",0.9994920967597407,0,0,2
273,T-cell receptor (TCR) signaling pathway WP69,0.9515799367038331,0.30438871473354234,0.015107294223829941,['NFATC2'],0.9994920967597407,0,0,1
274,ATM Signaling Pathway WP2516,0.9515799367038331,0.30438871473354234,0.015107294223829941,['GADD45A'],0.9994920967597407,0,0,1
275,Tryptophan metabolism WP465,0.9515799367038331,0.30438871473354234,0.015107294223829941,['DHCR24'],0.9994920967597407,0,0,1
276,Glioblastoma signaling pathways WP2261,0.9515799367038331,0.30438871473354234,0.015107294223829941,['FOXO4'],0.9994920967597407,0,0,1
277,TNF-alpha signaling pathway WP231,0.9682184299803235,0.3373451944880516,0.01089542880343545,"['BAD', 'SKP1']",0.9994920967597407,0,0,2
278,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9682184299803235,0.3373451944880516,0.01089542880343545,"['FRAT2', 'SFRP2']",0.9994920967597407,0,0,2
279,Prolactin Signaling Pathway WP2037,0.9682184299803235,0.3373451944880516,0.01089542880343545,"['SOCS3', 'CISH']",0.9994920967597407,0,0,2
280,Chemokine signaling pathway WP3929,0.9708088962067809,0.25339602925809823,0.0075070198904854495,['GNG3'],0.9994920967597407,0,0,1
281,ErbB signaling pathway WP673,0.9708088962067809,0.25339602925809823,0.0075070198904854495,['BAD'],0.9994920967597407,0,0,1
282,Hematopoietic Stem Cell Differentiation WP2849,0.9708088962067809,0.25339602925809823,0.0075070198904854495,['NFATC2'],0.9994920967597407,0,0,1
283,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9708088962067809,0.25339602925809823,0.0075070198904854495,['IFI27L2'],0.9994920967597407,0,0,1
284,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9708088962067809,0.25339602925809823,0.0075070198904854495,['NDUFA13'],0.9994920967597407,0,0,1
285,p53 transcriptional gene network WP4963,0.9708088962067809,0.25339602925809823,0.0075070198904854495,['GADD45A'],0.9994920967597407,0,0,1
286,Peptide GPCRs WP24,0.9708088962067809,0.25339602925809823,0.0075070198904854495,['HCRTR1'],0.9994920967597407,0,0,1
287,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9708088962067809,0.25339602925809823,0.0075070198904854495,['MYO1E'],0.9994920967597407,0,0,1
288,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9824084033332574,0.21697268248992388,0.003850867564755442,['MYL12B'],0.9994920967597407,0,0,1
289,PI3K-Akt signaling pathway WP4172,0.9856131828950087,0.3972272953677569,0.005756344191481849,"['FGF17', 'CREB3', 'GNG3', 'LAMB3', 'BAD']",0.9994920967597407,0,0,5
290,Nuclear Receptors Meta-Pathway WP2882,0.9865055842048575,0.4393459915611814,0.00596908333115848,"['CYP2A6', 'GADD45B', 'FTH1', 'PRDX1', 'GSTP1', 'AIP', 'SLC5A3']",0.9994920967597407,0,0,7
291,ESC Pluripotency Pathways WP3931,0.9894027094072813,0.1896551724137931,0.002020556195404882,['FGF17'],0.9994920967597407,0,0,1
292,Oncostatin M Signaling Pathway WP2374,0.9894027094072813,0.1896551724137931,0.002020556195404882,['SOCS3'],0.9994920967597407,0,0,1
293,Osteoblast differentiation WP4787,0.9894027094072813,0.1896551724137931,0.002020556195404882,['DLL3'],0.9994920967597407,0,0,1
294,MAPK Signaling Pathway WP382,0.9898565233084236,0.37697160883280756,0.0038433282041975274,"['FGF17', 'HSPA8', 'GADD45A', 'DDIT3', 'STMN1']",0.9994920967597407,0,0,5
295,Regulation of toll-like receptor signaling pathway WP1449,0.9936184156300945,0.16840822013235807,0.0010781551049202428,['CISH'],0.9994920967597407,0,0,1
296,Spinal Cord Injury WP2431,0.9964899198933591,0.21574344023323616,0.0007586089270030301,"['GADD45A', 'MIF']",0.9994920967597407,0,0,2
297,Gastrin signaling pathway WP4659,0.9976879150873887,0.13750356226845256,0.00031828800815643176,['BAD'],0.9994920967597407,0,0,1
298,Glucocorticoid Receptor Pathway WP2880,0.9976879150873887,0.13750356226845256,0.00031828800815643176,['GADD45B'],0.9994920967597407,0,0,1
299,"GPCRs, Class A Rhodopsin-like WP455",0.9994920967597407,0.2396220472440945,0.00012173573183680265,"['MAS1', 'CHRM5', 'NMUR2', 'HCRTR1']",0.9994920967597407,0,0,4
